Richard Gray

52.9k total citations · 15 hit papers
204 papers, 27.6k citations indexed

About

Richard Gray is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Richard Gray has authored 204 papers receiving a total of 27.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 32 papers in Surgery and 32 papers in Pathology and Forensic Medicine. Recurrent topics in Richard Gray's work include Breast Cancer Treatment Studies (26 papers), Colorectal Cancer Treatments and Studies (21 papers) and Acute Myeloid Leukemia Research (17 papers). Richard Gray is often cited by papers focused on Breast Cancer Treatment Studies (26 papers), Colorectal Cancer Treatments and Studies (21 papers) and Acute Myeloid Leukemia Research (17 papers). Richard Gray collaborates with scholars based in United Kingdom, United States and Sweden. Richard Gray's co-authors include Richard Peto, Keith Wheatley, Richard Doll, I. L. G. Sutherland, Jon Godwin, Paul McGale, Mike Clarke, Xiang Wang, Sarah C. Darby and Carolyn Taylor and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of the American Chemical Society.

In The Last Decade

Richard Gray

201 papers receiving 26.3k citations

Hit Papers

Mortality in relation to smoking: 40 years' observations ... 1980 2026 1995 2010 1994 2005 2011 2017 1994 1000 2.0k 3.0k

Peers

Richard Gray
Comparison fields: 5 of 200
  • Cancer Research 8.1k
  • Oncology 7.5k
  • Pathology and Forensic Medicine 4.6k
  • Pulmonary and Respiratory Medicine 4.3k
  • Surgery 4.3k
Replace Mark R. Somerfield with:
Mark R. Somerfield United States
Hyman B. Muss United States
Leslie Bernstein United States
­Eero Pukkala Finland
Graham G. Giles Australia
Jørgen H. Olsen Denmark
Nicholas Day United Kingdom
Alfred I. Neugut United States
Gary H. Lyman United States
John A. Baron United States
Mark R. Somerfield United States View profile →
Citations per field, relative to Richard Gray
Richard Gray · 1×
Citations per year, relative to Richard Gray
Richard Gray · 1×

Countries citing papers authored by Richard Gray

Since Specialization
Citations

This map shows the geographic impact of Richard Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Gray more than expected).

Fields of papers citing papers by Richard Gray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Gray. The network helps show where Richard Gray may publish in the future.

Co-authorship network of co-authors of Richard Gray

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Gray. A scholar is included among the top collaborators of Richard Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Gray. Richard Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial breakdown →
181
2 14
3 24
4
Regional lymph node irradiation in early stage breast cancer: An EBCTCG meta-analysis of 13,000 women in 14 trials
7
5
Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer
17
6
Value of Mismatch Repair, KRAS , and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer breakdown →
505
7 84
8 78
9 42
10 147
11
Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials breakdown →
675
12 93
13
Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin breakdown →
581
14
Impact of diagnostic cytogenetics on outcome in AML: Analysis of 1,613 patients entered into the UK MRC AML 10 trial.
6
15
A simple, robust and highly predictive prognostic index for the determination of risk directed therapy in acute myeloid leukaemia (AML) derived from the United Kingdom medical research council (MRC) AML10 trial.
13
16
Intensive chemotherapy with or without additional bone marrow transplantation in paediatric AML:Progress report on the MRC AML 10 trial
2
17
Intensive chemotherapy with or without additional bone marrow transplantation in paediatric AML: progress report on the MRC AML 10 trial. Medical Research Council Working Party on Childhood Leukaemia.
3
18 16
19 274
20 83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026